Lower Pregnancy Rates with Prolonged Storage of Frozen Embryos
There are many reasons why women choose to freeze their embryos instead of trying to transfer them immediately. The pregnancy and birth results of freezing all embryos have been shown to be just as effective as fresh embryo transfers; some studies have shown that frozen embryos produce more pregnancies than fresh transfers. For many women who, for personal choice or for medical necessity (impending cancer treatment), this is now a solid option. Also, for those who prefer to have genetic testing conducted prior to transfer, freezing is almost always required because it takes too much time to report genetic results before an embryo loses viability in culture.
Possible risks of embryo freezing include the following: bacterial contamination, ice crystal formation, premature warming, and reduced viability over time. Today’s study looks at that last risk, comparing how embryos fare over time.
Study Background
WHAT
Does the storage time of a frozen embryo impact rates of pregnancy?
Does the storage time of a frozen embryo impact newborns? Does it cause early delivery? Does it change birth weight? Does it cause birth defects?
WHERE
a large, hospital-based reproductive center in Shanghai, China
WHEN
January 2011 - December 2017
WHO
Inclusion criteria: any type of infertility diagnosis or patient preference leading to a freeze-all embryo cycle (includes women with diminished ovarian reserve, polycystic ovary syndrome (PCOS), poor ovarian response, advanced maternal age, tubal factor, male factor, and endometriosis)
Exclusion criteria: prior fresh or frozen embryo transfers, transferring non-biological embryos, pre-implantation genetic testing (PGD) of embryos, or transfer of mixed cleavage-stage embryos-blastocysts
HOW
Frozen Embryo Creation
Ovulation induction (protocols not stated) then IVF +/- ICSI
Starting Day 0: embryos in single-culture medium (Irvine Scientific, USA) in incubator (Astec, Japan) at 5% CO2/5% O2 at 98.6°F/ 37°C
Starting Day 3:
blastocyst assessment, double-checked by senior embryologist—> retained blastocysts with quality higher than Grade 3CC
blastocyst cryopreservation by vitrification
equilibration solution = mHTF medium (Irvine Scientific, USA) + 7.5% (v/v) ethylene glycol + 7.5% dimethysulfoxide (DMSO) + 20% synthetic serum substitute (SSS)
vitrification solution = mHTF medium with 15% ethylene glycol, 15% DMSO, 0.5 mol/L sucrose and 20% SSS
final solution = liquid nitrogen (USA) at -320.8°F/ 196°C
Frozen Embryo Thawing
Thawed in “basic medium” + 0.5-1.0 mol/L sucrose and 20% SSS
Washed in “basic medium” + 20% SSS
Cultured until transfer in mHTF medium + 10% SSS in incubator at 5% CO2/5% O2 at 98.6°F/ 37°C
Female Patient
Completed natural, stimulated, or hormone induction pre-transfer cycles, per patient health
Received 1-2 embryos in blastocyst or cleavage-stage, per patient age/embryo quality/embryo quantity
Took progesterone (formulation not specified) from transfer date until eight weeks of pregnancy
At 14 days post-transfer, blood test for hCG
At 35 days post-transfer, vaginal ultrasound if hCG +
Statistics (for the uber curious)
Controlled for possible confounders, including maternal age, maternal BMI, infertility type, parity, infertility causes, embryo quality, number of transferred embryos, stage of embryo development, endometrial preparation program and treatment years
Reported as adjusted odds ratios (aOR) with 95% CI using two-sided significance of 5%
See page 3 of study for further details
Results
There were four embryo groups. Group 1 were embryos with a storage time of 0–3 months; Group 2 was embryos with a storage time 3–6 months; Group 3 had a storage time 6–12 months and Group 4 had a storage time 12–24 months. This study excluded transfers of embryos stored longer than 24 months.
Pregnancy: This study found that the rate of clinical pregnancy dropped from 56% in Group 1 (which had the embryos frozen less than three months) to 26% pregnancy rates in Group 4 (the group that had storage times of 12-24 months). The live birth rates decreased as well, with Group 1 having 47% of women give birth vs. 26% in Group 4. Rates of miscarriage and ectopic pregnancy increased with prolonged storage time, but these numbers were not statistically significant, which means that these differences could have occurred due to random chance.
Newborns: The happiest results of the study were that, regardless of how long the embryo was frozen, it did NOT impact the health of the newborn. Storage time did NOT lead to a difference in birth defects, being born prematurely, or having an unhealthy birth weight. Notably, when assessing newborn outcomes, the authors did NOT include twin births, which may have skewed the results.
Authors’ Thoughts
Recognized that women with diminished ovarian reserve (aka poor ovarian reserve) tended to store embryos longer
Acknowledged main limitations of study were retrospective nature and lack of long-term follow-up of newborns
This Pharmacist’s Thoughts
Study Strengths
Large enough to detect differences if differences exist
Well written article
Authors clearly understood previous research
Process of vitrification explained well
Study Weaknesses
Did variations within the study impact the results?
What were the doses and formulations of the progesterone supplements? Did they vary based on patient factors or clinician preference?
Natural vs. artificial cycles to prepare for transfer
Transfer of one vs. two embryos
87.6% Group 1 vs. 68.7% Group 4 had two embryos transferred
twins born were excluded from neonatal outcomes
Transfer of blastocyst vs. cleavage-stage embryo
Included more cleavage-stage embryos though blastocysts tend to thaw better
Not generalizable to other IVF centers based on variations at this single IVF center
Women with low ovarian reserve tended to store embryos longer - 3.8% in Group 1 vs. 13.25% in Group 4 - how did this impact the results?
Time will tell how these results compare to those at other reproductive centers. In progress is a randomized controlled trial that involves more reproductive centers and it includes embryos frozen more recently (2015-2020).
Resources
Alikani M. Cryostorage of human gametes and embryos: a reckoning. Reprod Biomed Online. 2018;37(1):1-3. doi:10.1016/j.rbmo.2018.05.004
Maheshwari A, Bhattacharya S, Bowler U, et al. Study protocol: E-freeze - freezing of embryos in assisted conception: a randomised controlled trial evaluating the clinical and cost effectiveness of a policy of freezing embryos followed by thawed frozen embryo transfer compared with a policy of fresh embryo transfer, in women undergoing in vitro fertilisation. Reprod Health. 2019;16(1):81. Published 2019 Jun 13. doi:10.1186/s12978-019-0737-2
Nagy ZP, Shapiro D, Chang CC. Vitrification of the human embryo: a more efficient and safer in vitro fertilization treatment. Fertil Steril. 2020;113(2):241-247. doi:10.1016/j.fertnstert.2019.12.009
Rezazadeh Valojerdi M, Eftekhari-Yazdi P, Karimian L, Hassani F, Movaghar B. Vitrification versus slow freezing gives excellent survival, post warming embryo morphology and pregnancy outcomes for human cleaved embryos. J Assist Reprod Genet. 2009;26(6):347-354. doi:10.1007/s10815-009-9318-6